76 related articles for article (PubMed ID: 1539354)
21. Treatment with angiotensin-converting enzyme inhibitors in renal transplantation with proteinuria.
Oppenheimer F; Flores R; Cofán F; Campistol JM; Ochs J; Ricart MJ; Vilardell J; Torregrosa JV; Darnell A; Carretero P
Transplant Proc; 1995 Aug; 27(4):2235-6. PubMed ID: 7652787
[No Abstract] [Full Text] [Related]
22. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
[TBL] [Abstract][Full Text] [Related]
23. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
Montanaro D; Gropuzzo M; Tulissi P; Vallone C; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
Transplant Proc; 2005 Mar; 37(2):991-3. PubMed ID: 15848600
[TBL] [Abstract][Full Text] [Related]
24. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
[No Abstract] [Full Text] [Related]
25. Proteinuria after renal allograft: assessment based on severity and causes.
Jeong HJ; Kim YS; Oh CK; Park K; Choi IJ
Transplant Proc; 1994 Aug; 26(4):2132-3. PubMed ID: 8066695
[No Abstract] [Full Text] [Related]
26. Deteriorated renal allograft function after development of chronic rejection in pediatric renal transplantation.
Shishido S; Kawamura T; Nakai H; Higuchi A; Gakiya M; Kamiyama Y; Honda M; Morita M; Sakaguchi H; Hoshinaga K
Transplant Proc; 1994 Apr; 26(2):943-4. PubMed ID: 8171712
[No Abstract] [Full Text] [Related]
27. Erythrocytosis after renal transplantation: risk factors and relationship with GFR.
Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR
Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630
[TBL] [Abstract][Full Text] [Related]
28. Combined heart and kidney transplantation.
Benvenuti C; Bourgeon B; Chopin D; Deleuze P; Aptecar E; Mourtada A; Baron C; Lebesneraie P; Remy P; Abbou C
Transplant Proc; 1995 Apr; 27(2):1694. PubMed ID: 7725457
[No Abstract] [Full Text] [Related]
29. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
30. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage.
Lufft V; Kliem V; Hamkens A; Bleck JS; Eisenberger U; Petersen R; Ehlerding G; Maschek H; Pichlmayr R; Brunkhorst R
Clin Transplant; 1998 Oct; 12(5):409-15. PubMed ID: 9787950
[TBL] [Abstract][Full Text] [Related]
31. Effect of captopril in the treatment of erythrocytosis after renal transplantation.
Suh BY; Suh JD; Kwun KB
Transplant Proc; 1996 Jun; 28(3):1557-8. PubMed ID: 8658784
[No Abstract] [Full Text] [Related]
32. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between the onset of early proteinuria and the outcome of renal transplantation. Experience of a single centre].
Infante B; Stallone G; Schena A; Di Paolo S; Grandaliano G; Schena FP
G Ital Nefrol; 2002; 19(4):446-50. PubMed ID: 12369048
[TBL] [Abstract][Full Text] [Related]
34. Correlation between proteinuria and prognosis of transplant IgA nephropathy.
Kimata N; Tanabe K; Ishikawa N; Ozu H; Sonda K; Yumura W; Toma H; Nihei H; Ota K; Takahashi K
Transplant Proc; 1996 Jun; 28(3):1537-9. PubMed ID: 8658776
[No Abstract] [Full Text] [Related]
35. Clinical and psychosocial consequences of renal transplantation in children.
Park CH; Kim DY; Kim KS; Cho WH; Park SB; Kim HC
Transplant Proc; 1996 Jun; 28(3):1604-6. PubMed ID: 8658804
[No Abstract] [Full Text] [Related]
36. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
[TBL] [Abstract][Full Text] [Related]
37. Analysis of serum ferritin changes after kidney transplantation: a prospective study of 123 cases.
Lataste A; Renoult E; Lederlin P; Kessler M
Transplant Proc; 1994 Aug; 26(4):2001-5. PubMed ID: 7520618
[No Abstract] [Full Text] [Related]
38. Serum erythropoietin levels after renal transplantation with various graft outcomes.
Ghods AJ; Arghani H; Ghadiri G
Transplant Proc; 1995 Oct; 27(5):2577-8. PubMed ID: 7482834
[No Abstract] [Full Text] [Related]
39. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
Imai E; Takenaka M; Isaka Y; Moriyama T; Akagi Y; Kakuchi J; Fujii T; Ito T; Hori M; Horio M; Syoji T; Tsubakihara Y
Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
[TBL] [Abstract][Full Text] [Related]
40. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
Hay U; Ludvik B; Gisinger C; Schernthaner G
Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
